Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2581 of 5804
-
Machine learning may crack the code of OCD therapy
Knowledge-focused Recruiting nowExposure therapy is the most effective treatment available for obsessive compulsive disorder, yet up to 50% of patients do not recover because the mechanisms underlying successful response are poorly understood, leading to significant variability in how clinicians conduct exposur…
Phase: NA • Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New antibody injection enters early human trials for lung cancer
Disease control Recruiting nowThis study is an open-label, multicenter, dose-escalation and cohort expansion phase I clinical study to evaluate the safety, tolerability, pharmacokinetics characteristics or preliminary efficacy and antitumor activity in patients with Locally advanced or metastatic non-small ce…
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New tool aims to boost colon cancer screening in primary care
Prevention CompletedThe research question we pose is, Does a colorectal cancer (CRC) screening decision support tool offered in advance of primary care visits increase CRC screening completion rates? Our work aims to answer this question by evaluating the effectiveness of an MGB decision support too…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:04 UTC
-
Could a pill ease lewy body dementia? small trial tests safety
Disease control CompletedThe purpose of this clinical study is to evaluate the safety and tolerability (side effects) and pharmacokinetics (drug levels in the body) of 80mg neflamapimod given twice daily in patients with dementia with Lewy bodies.
Phase: PHASE2 • Sponsor: EIP Pharma Inc • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Memory boost may help older vets beat PTSD
Symptom relief Recruiting nowSeveral psychotherapies for posttraumatic stress disorder (PTSD) have a strong evidence base for their efficacy, but nonresponse rates are high, particularly among older Veterans. Accumulating evidence indicates that memory deficits and poor learning of therapy contents adversely…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New online program boosts sexual health for young breast cancer survivors
Symptom relief CompletedThe goal of this clinical trial is to test the efficacy of a nurse-led psychoeducational sexual health intervention for young women breast cancer survivors. The main questions it aims to answer are: 1. What is the feasibility of this intervention in an online, private setting? 2…
Phase: NA • Sponsor: University of Arkansas • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Could a common sedative shield the brain after injury?
Disease control CompletedThe aim of the study is to check whether dexmedetomidine has neuroprotective properties in brain injury patients. The enrolled 60 patients will be divided into two groups; Group 1(n=30): are the patients who will receive dexmedetomidine. Group 2 (n=30): are the patients who repre…
Phase: NA • Sponsor: Damanhour University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Acupuncture needles vs. ADHD: new study tests ancient therapy for hyperactive kids
Symptom relief Recruiting nowThis study aims to evaluate the efficacy of acupuncture as a treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6-12 years. Using a mixed-methods approach, the research will triangulate data from acupoint data mining, treatment outcomes assessment, and…
Phase: NA • Sponsor: The Third Affiliated Hospital of Beijing University of Chinese Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Can treating mom's depression also help her child's asthma?
Symptom relief Recruiting nowThe goal of this clinical trial is to test the effectiveness and implementation of delivering Enhanced Brief Interpersonal Psychotherapy (IPT-B), an evidence-based maternal depression treatment, to mothers of children under the age of 18 in an urban pediatric asthma clinic. Resea…
Phase: NA • Sponsor: Children's National Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Maitake mushroom extract tested as immune booster for cancer patients
Disease control Recruiting nowMaitake is an edible mushroom that is used for both its nutritional and medicinal properties. Human and animal studies have shown Maitake may help improve immune function; however, its effectiveness in people with cancer is not clear. The investigators aim to measure if Maitake h…
Phase: PHASE2 • Sponsor: The Canadian College of Naturopathic Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New eye drops aim to boost tears in dry eye sufferers
Symptom relief CompletedThe purpose of this study is to evaluate tear production following acute administration of AR-15512 ophthalmic solution 0.003% (0.003% AR-15512) in subjects with dry eye disease (DED).
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Can a Dye-Guided massage stop arm swelling in breast cancer patients?
Symptom relief Recruiting nowBreast cancer is estimated to affect approximately 300,000 women in the US in 2023. Studies demonstrate that 1 in 5 will develop breast cancer related lymphedema secondary to the treatments that they receive. BCRL at this time has no cure, however early detection can prevent the …
Phase: PHASE2 • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Laser therapy offers hope for cancer survivors with menopause symptoms
Symptom relief OngoingThis pilot study is designed to evaluate an individualized approach to the treatment of genitourinary syndrome of menopause (GSM) in women who have undergone oncological treatment. GSM is a common condition in postmenopausal women and may include symptoms such as vaginal dryness,…
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
AI to uncover hidden social risks for brain aneurysm patients
Knowledge-focused OngoingIntracranial aneurysms (IA) are arterial malformations affecting about 3% of the overall population. Rupture is the most severe complication, as it is associated with nearly 30% of death or severe disability. The available scores to assess rupture risk are mainly based on usual m…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Short therapy shows promise for refugee mental health
Symptom relief CompletedRefugees and asylum seekers (RAS) face numerous stressors and adversities which put them at risk for developing mental health problems. However, access to adequate mental health care in host countries is limited. To address this problem, the World Health Organization (WHO) introd…
Phase: NA • Sponsor: University of Zurich • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Could a common decongestant plus steroid spray finally ease stubborn stuffy noses?
Symptom relief Recruiting nowThis study aims to examine the efficacy and safety of commination oxymetazoline/intranasal steroids for long-term management of chronic nasal obstruction that is recalcitrant to the current standard of care. The investigators hypothesize that combination treatment with oxymetazol…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 26, 2026 15:43 UTC
-
Can a cuff ease knee pain? new study tests blood flow restriction
Symptom relief OngoingThis clinical trail will be conducted to investigate the effect of blood flow restriction (BFR) with different load levels between low blood occlusion percentage (50%) group and high blood occlusion percentage (70%) compared to moderate intensity training (60% of 1 RM) in patient…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New drug JNJ-89402638 enters human trials for Tough-to-Treat GI cancers
Disease control Recruiting nowThe purpose of this study is to determine the putative recommended phase 2 dose(s) (RP2Ds) and best way to take (optimal route of administration) JNJ-89402638 and to determine the safety of JNJ-89402638 at the RP2D(s) in participants with metastatic colorectal cancer (mCRC) and m…
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a phone app soothe postpartum depression? new trial tests 'Serene Motherhood'
Symptom relief OngoingEffectiveness of a Smartphone Application for Mothers at High Risk for Postpartum Depression: A Randomized Controlled Trial Abstract Aim: This study aims to determine the effectiveness of a smartphone application in reducing symptoms of postpartum depression among Jordanian wome…
Phase: NA • Sponsor: Jordan University of Science and Technology • Aim: Symptom relief
Last updated Jun 26, 2026 16:23 UTC
-
Spinal morphine may ease pain and speed recovery after colon cancer surgery
Symptom relief ENROLLING_BY_INVITATIONColorectal cancer is the second most common tumor in women and the third most common tumor in men, accounting for approximately 10% of tumors diagnosed and tumor-related deaths worldwide each year. Laparoscopic resection has become the standard of colorectal cancer surgery, and i…
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC